Psychiatry ·
VA to require signed consent for some psychotropics; CDC finds suicides were 62.4% of violent deaths; Medicare raises psychiatric facility rates 2.3%
THE SHORT READ
The Department of Veterans Affairs (VA) announced Sept. 28 that, starting in 2027, it will require signature consent before prescribing antidepressants to veterans younger than 30 and before concurrent opioid and benzodiazepine prescriptions.
Data from the Centers for Disease Control and Prevention (CDC) showed suicides made up 62.4% of 72,093 violent deaths in 2023, and a 2.3% Medicare payment update for inpatient psychiatric facilities took effect Oct. 1.
THE DETAILS
- Policy Sept 28, 2026The Department of Veterans Affairs announced Sept. 28 new informed consent guidance for psychotropic medications, including antipsychotics, stimulants, antidepressants, anxiolytics and opioids. Starting in 2027, the department will require patient education and signature consent before concurrent prescription of opioids and benzodiazepines and before prescribing antidepressants to veterans younger than 30. It will also standardize patient education for veterans prescribed psychotropic medications and require documented discussions of risks, side effects, benefits, alternatives and safe discontinuation, including for medications that need only oral consent.Source: Department of Veterans Affairs
- Public health Oct 1, 2026The National Violent Death Reporting System of the Centers for Disease Control and Prevention collected data on 70,133 incidents involving 72,093 deaths in 2023, and suicides (44,966) accounted for 62.4% of all deaths, according to a surveillance summary published Oct. 1. The suicide rate for males, 23.5 per 100,000, was nearly four times the rate for females, 6.1, and a firearm was used in 54.5% of suicides. Among suicide decedents with circumstance data, 22.3% were receiving mental health or substance use treatment at the time of death.Source: CDC MMWR Surveillance Summaries
- Payment Oct 1, 2026The fiscal 2027 inpatient psychiatric facility (IPF) payment rule from the Centers for Medicare & Medicaid Services (CMS) took effect Oct. 1, updating rates by 2.3%, a 3.2% market basket increase reduced by a 0.9 percentage point productivity adjustment. CMS estimated payments to IPFs will rise by $60 million. The rule implements a standardized IPF patient assessment instrument, removes alcohol use brief intervention and tobacco use treatment measures starting with calendar 2026 reporting, and finalizes a provider-level outlier payment cap with its effective date deferred to fiscal 2028.
The weekly roundup for psychiatry, published every Monday for the week before; every item links to its sources. Latest psychiatry news · All specialties